astragaloside a has been researched along with Cardiotoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, L; Li, H; Li, Z; Lin, J; Lyu, L; Wang, H; Xiao, J | 1 |
1 other study(ies) available for astragaloside a and Cardiotoxicity
| Article | Year |
|---|---|
Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
Topics: Animals; Body Weight; Cardiomyopathies; Cardiotoxicity; Cell Size; Doxorubicin; Gene Expression Regulation; Male; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidase 4; Organ Size; Oxidative Stress; Rats; Saponins; Triterpenes | 2019 |